Unraveling a novel therapeutic facet of Etravirine to confront Hepatocellular Carcinoma via disruption of cell cycle

Abstract Hepatocellular Carcinoma (HCC) is a malignancy with high mortality rates and limited treatment options. This study aimed to unearth the repurposable potential of FDA-approved drugs against specific genetic targets governing the HCC pathological pathways. The transcriptomics microarray datas...

Бүрэн тодорхойлолт

Номзүйн дэлгэрэнгүй

Үндсэн зохиолчид:	Gouri Nair, G. R. Saraswathy, Jesil Mathew Aranjani, Rafwana Ibrahim
Формат:	Artigo
Хэл сонгох:	Inglês
Хэвлэсэн:	Nature Portfolio 2025-02-01
Цуврал:	Scientific Reports
Нөхцлүүд:	Hepatocellular Carcinoma Drug repurposing CCNA2 CDK1 CDK2 Etravirine
Онлайн хандалт:	https://doi.org/10.1038/s41598-025-87676-3
Шошгууд:	Шошго нэмэх Шошго байхгүй, Энэхүү баримтыг шошголох эхний хүн болох!